National Drugs Authority (NDA) has suspended registration of products from drug manufacturing companies over counterfeit.
NDA is mandated to ensure that Ugandans have access to safe, effective and quality drugs.
“We received market complaints on quality of different pharmaceutical products. Some of the complaints were related to the occurrence of serious adverse events whereas other products had critical defects posing a risk to public health,” the letter signed by NDA, Director Product Safety, Helen Byomire Ndagije reads. Further investigations revealed that the manufacturing facilities of some of the drugs did not comply with Good Manufacturing practices (GMP) requirements.
The banned drugs include; R-ether, Gmycin-80, Falcimax-600, Artemether injection, Quinine dihydrocholride injection, Diclomax-75, Gentamycin injection, Vitamin B injection, Diclofenac injection, Celltriaxon, Expen and Procilin. The mentioned drugs are manufactured by Jiangsu Pengyao Pharmaceuticals Company Limited, Anhuichengsi medicine manufacturing company and Shandong xier-kangtai pharmaceutical company limited.
NDA has advised health workers not to purchase any injectable products manufactured by the companies listed above and also quarantine and return all o the affected products to their suppliers.
